This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

An Experimental Study

CLARENCE H. WALTON, M.D.; JUDD W. UHL, M.D.; WILLADENE M. EGNER, B.S.; H. M. LIVINGSTONE, M.D.

Arch Surg. 1950;60(5):986-994.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE ANESTHETIC management of surgical patients with hepatic damage is difficult and perplexing, particularly from the standpoint of postoperative and postanesthetic morbidity. While it is generally recognized that damage to the liver produced by certain anesthetic agents is simply one manifestation of an over-all metabolic depression and largely preventable by adequate oxygenation, careful preoperative attention to the vitamin K level and the carbohydrate and nitrogen balance.¹ the question of specific hepatotoxicity must still be considered. In this regard attention has been focused on the barbiturates, since some of these drugs are detoxified in the liver² and have been known to produce prolonged toxicity in patients with damaged livers. Certain thiobarbiturates administered orally to animals over long periods have been shown by Kohn-Richards³ to cause hepatic damage. Since thiopental sodium (pentothal sodium®) is a thiobarbiturate and earlier reports indicated prolonged narcosis in the presence of hepatic disease,⁴ . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO

From the Department of Surgery (Anesthesia) of the University of Chicago.

Footnotes
Aided by grants from the Ella Sachs Plotz Foundation and the Office of Naval Research, N6 ori-20, task order 11.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?